Charlesworth, G., & Balint, B. (2016). SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy. Movement disorders, 31(8), . https://doi.org/10.1002/mds.26716
Chicago-Zitierstil (17. Ausg.)Charlesworth, Gavin, und Bettina Balint. "SLC25A46 Mutations Underlie Progressive Myoclonic Ataxia with Optic Atrophy and Neuropathy." Movement Disorders 31, no. 8 (2016). https://doi.org/10.1002/mds.26716.
MLA-Zitierstil (9. Ausg.)Charlesworth, Gavin, und Bettina Balint. "SLC25A46 Mutations Underlie Progressive Myoclonic Ataxia with Optic Atrophy and Neuropathy." Movement Disorders, vol. 31, no. 8, 2016, https://doi.org/10.1002/mds.26716.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.